With the market for GLP-1 weight-loss drugs increasing rapidly, consumer apps that send reminders, track progress, and explain side effects, are emerging
Storage Requirements Store in a refrigerator at 2C8C (36F46F)
October 2023: A study suggested that patients with obesity who took Glucagon-like Peptide-1 Receptor Agonists (such as Ozempic) for weight loss had a higher risk of gastroparesis than those in the dataset who took bupropion-naltrexone
Combination therapy (for example, with metformin) can modestly influence outcomes, but **individual response varies**
Patients should maintain adequate hydration and contact their healthcare provider if experiencing severe or persistent symptoms
Answer: BPC-157 and TB-500 are both synthetic (laboratory-made) peptides that have been promoted for many uses based mainly on findings in animal studies: BPC-157 for improving bone and joint health, stomach ulcers, bladder pain, athletic performance enhancement, and anti-aging effects, and TB-500 for wound healing, injury recovery, strength and endurance